New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance

Details for Australian Patent Application No. 2003251732 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors De Bethune, Marie-Pierre T.M.M.G; Vingerhoets, Johan Hendrika Jozef; Azijn, Hilde

Agent Shelston IP

Pub. Number AU-B-2003251732

PCT Number PCT/EP03/50280

PCT Pub. Number WO2004/003223

Priority 60/393,005 01.07.02 US

Filing date 30 June 2003

Wipo publication date 19 January 2004

Acceptance publication date 18 September 2008

International Classifications

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/393,005 01.07.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003251732

18 September 2008 Application Accepted

  Published as AU-B-2003251732

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251733-APPLICATOR FOR OBJECTS SUCH AS TAMPONS

2003251731-New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance